Clinical Research Experience

Clinical research is an important part of NGBC. The department operates under the direction of Kenneth A. Levin, MD, Principal Investigator and Director of Clinical Research. Participation in any research study is approved by Dr. Levin.

NGBC has had extensive experience in research and clinical trials participating in over 150 studies integrating research into the following therapeutic specialty areas:

• Acute stroke
• Alzheimer's
• Atrial fibrillation
• Attention deficit hyperactivity disorder (ADHD)
• Botox for pain and spasticity
• Cancer pain
• Cerebral palsy
• Chronic fatigue
• Chronic pain management
• Epilepsy
• Erectile dysfunction
• Migraine (adult and adolescent)
• Minor stroke/TIA
• Multiple sclerosis
• Parkinson's
• Peripheral neuropathy
• Post-op pain
• Trigger point injections
• Stroke prevention
• Dementia
• Hypercholesterolemia
• Headache
• Diabetic neuropathy

NGBC neurologists have worked with the following sponsors/CRO's and pharmaceutical companies:

• Pfizer
• Bristol Myers Squibb
• Novartis
• Noven
• AstraZeneca
• Knoll Pharmaceutical
• Janssen Pharmaceutical
• Serono, Inc.
• Texas Biotechnology
• Mylan Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson
• Pharmacia
• Parke-Davis
• Columbia University
• Interneuron Pharmaceutical
• ICOS Corporation
• Procter and Gamble
• EpiCept Corporation
• Merck Co.
• Elan Pharmaceutical
• Sanofi-Synthelabo
• Allergan
• Berlex Labs
• Schering-Plough Pharmaceutical
• Wyeth Ayerst Research
• Algos Pharmaceutical
• Rhone-Poulenc Rorer
• Cato Research
• Ono Pharmaceuticals
• Boehringer Ingelheim
• Abbot Labs
• Bayer Pharmaceuticals
• Eli Lilly

About the Principal Investigator

Dr. Kenneth A. Levin serves as the Principal Investigator for the Clinical Trials Program. He is board certified by the Board of Psychiatry and Neurology and the Academy of Pain Management. He has over 18 years experience in private practice and clinical trial research. He is a member of the National Headache Foundation, American Heart Association Stroke Council, American Academy of Pain Management and the Movement Disorder Society. Dr. Levin is Director of The Valley Hospital Stroke Center and Senior Affiliate Physican to Columbia University, NYC. Under Dr. Levin's direction, The Valley Hospital was recently awarded the Joint Commission Disease-Specific Care Certification for Stroke. Dr. Levin has most recently authored "Intravenous Ancrod for Treatment of Acute Ischemic Stroke, The STAT Study: A Randomized Controlled Trial." JAMA, May 10, 2000.

Sub-Investigators for the Neurology Group's Clinical Trials Program

• Reed C. Perron, M.D., Neurologist
• Hugo N. Lijtmaer, M.D., Neurologist
• Daniel R. Van Engel, M.D., Neurologist
• Judith P. Lustig, M.D., Neurologist
• Kenneth Citak, M.D., Neurologist
• James T. Shammas, M.D., Neurologist
• Susan P. Molinari, M.D., Neurologist
• John T. Nasr, M.D., Neurologist
• Peter L. Heilbroner, M.D., Ph.D., Pediatric Neurologist
• Jennifer A. Cope, M.D., Pediatric Neurologist
• Mitchell Steinschneider, M.D., Pediatric Neurology Consultant
• Geraldine Fee, Ph.D., Biofeedback Therapy, Psychophysiology

The Clinical Trials Program Support Staff Team

Lillian A. Warnock, R.N.
Senior Clinical Research Coordinator

Stacey A. Pipala, R.N.
Clinical Research Coordinator

Bonnie A. Siebert
Clinical Research Administrator

Patient Demographics

Due to the location of NGBC, we enjoy a vast and diverse patient population. The majority of our clinical trial patients are from the NGBC private database. Due to our personal relationship with these patients, they are motivated to comply with study protocols.

Currently Enrolling Trials

We are recruiting patients at this center for the following studies:

• Alzheimer's disease
• Memory loss
• Parkinson's disease
• Multiple sclerosis
• Headaches
• Epilepsy
• Stroke/TIA
• Stroke prevention
• Chronic pain
• ADD/ADHD
• Post herpetic neuralgia
• Diabetic polyneuropathy
• Post-stroke spasticity
• Back pain

Contact Information

For more information, please contact:
Bonnie A. Siebert
Neurology Group of Bergen County, P.A.
1200 E. Ridgewood Avenue
Ridgewood, NJ 07450 USA
Tel: 201.612.3089
Fax: 201.251.9232
E-mail: bsiebert@neurobergen.com

Also, visit our clinical trials site at: www.centerwatch.com/ngbc